Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The European Magnetic Resonance Imaging in MS group (MAGNIMS) consists of nine different centres, collaborating on research and expert guidelines in the field. 

Our Neuromyelitis Optica and Multiple Sclerosis teams hosted a very successful 37th meeting of the MAGNIMS group at Wolfson College Oxford in May 2022, which marked 20 years of this collaboration. Sponsorship from UCB, Roche and Alexion made it possible.

The workshop topic was 'Identifying imaging features of MOG Antibody Disease (MOGAD) and differentiating it from MS : towards producing MOGAD imaging criteria'. This fits in with Oxford's highly specialised expertise in MOGAD and Neuromyelitis Optica. Experts in pathology and neuroimmunology as well as imaging participated, with speakers from Europe and the US. A review publication from the workshop is now planned.

The meeting was fully subscribed with 80 in-person participants and 30 people joining online. Ruth Geraldes and Silvia Messina provided a punting lesson for delegates. A celebratory cake included a model brain, although the two pathologists were not impressed!  

Similar stories

Experts hold first meeting for new international project on depression, anxiety and psychosis

The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, has launched in central London.

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.